Gary M. Phillips, Exec. VP & Chief Strategy Ofcr at Mallinckrodt, holds 14.81K shares in Aldeyra Therapeutics (Ticker: ALDX), holds 0.00 shares in Zyla Life Sciences (Ticker: ZCOR), holds 21.18K shares in Mallinckrodt (Ticker: MNKKQ). Most recently, Gary M. Phillips Bought ― shares of Aldeyra Therapeutics on Sep 11, 2023 for an estimated value of 2.99K.